MIRA
INFORM REPORT
|
Report Date : |
25.08.2008 |
IDENTIFICATION
DETAILS
|
Name : |
GLOBAL CALCIUM
PRIVATE LIMITED |
|
|
|
|
Registered Office : |
No. 126, SIPCOT Industrial Complex, Hosur – 635126, Dharmapuri
District, Tamilnadu |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
02.11.2001 |
|
|
|
|
Com. Reg. No.: |
18-9946 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U02429TZ1979PTC009946 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
CHEG00057B |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of Business : |
Manufacturing and exporting of Calcium Sodium and its compounds,
and other chemicals. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED
CREDIT LINE |
|
|||
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|||
|
Maximum Credit Limit : |
USD 700000 |
|||
|
|
|
|||
|
Status : |
Good |
|||
|
|
|
|||
|
Payment Behaviour : |
Regular |
|||
|
|
|
|||
|
Litigation : |
Clear |
|||
|
|
|
|||
|
Comments : |
Subject is a well
established and reputed company having satisfactory track. Directors are reported as experienced and respectable
businessmen. Trade relations are
fair. Business is active. Payments are reported as usually correct
and as per commitments. The company can
be considered normal for business dealings at usual trade terms and
conditions. |
|||
|
|
|
|
|
|
|
LOCATIONS
|
Registered Office/ Factory : |
No. 126, SIPCOT Industrial Complex, Hosur – 635126, Dharmapuri District, Tamilnadu, India |
|
Tel. No.: |
91-4344-500683/276958/276959/276235 |
|
Fax No.: |
91-4344-576359/276359 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate
Office : |
Koramangala, IIIrd Block, Bangalore -560 034, Karnataka, India |
|
Tel. No.: |
91-80-25523119/ 25520831/ 25530831/ 25531752 / 25535374 |
|
Fax No.: |
91-80-25530807 |
|
E-Mail : |
|
|
|
|
|
Corporate
Office : |
No. 1, Hundred Feet Road,
5th Block, Koramangala, Bangalore-560095, Karnataka, India |
|
Tel. No.: |
91-80-40554500 |
|
Fax No.: |
91-80-25530807 |
|
E-Mail : |
infoQglobalcalciumpharma.com |
|
|
|
|
Branches : |
30, Rajaji Salai, Hongkong Bank Building, Chennai – 600 001,
Tamilnadu, India |
|
Tel. No.: |
91-44-5263946 |
|
Fax No.: |
91-44-5223217 |
|
E-Mail : |
DIRECTORS
|
Name : |
Mr. Arif
Vazirally |
|
Designation : |
Managing Director
|
|
Address : |
381, Sarjapur
Road, Koramangala, III Block, Bangalore – 560034, Karnataka, India |
|
Date of Birth/Age : |
16.03.1949 |
|
Date of Appointment : |
10.10.1979 |
|
|
|
|
Name : |
Mr. Master Masoom |
|
Designation : |
Director |
|
Address : |
Christmas Eve,
Westfield Estate, 63Q BD Road, Mumbai – 400026, Maharashtra, India |
|
Date of Birth/Age : |
12.10.1939 |
|
Date of Appointment : |
10.10.1979 |
|
|
|
|
Name : |
Mr. M.
Chandrasekar |
|
Designation : |
Director |
|
Address : |
B9 & 10,
Sipcot Housing Colony, Hosur – 635126, Dharmapuri, Tamilnadu, India |
|
Date of Birth/Age : |
10.08.1953 |
|
Date of Appointment : |
31.08.1999 |
|
|
|
|
Name : |
Mr. Nahid
Vazirally |
|
Designation : |
Director |
|
Address : |
381, Sarjapur Road,
Koramangala, III Block, Bangalore – 560034, Karnataka, India |
|
Date of Birth/Age : |
07.08.1953 |
|
Date of Appointment : |
28.06.2002 |
|
|
|
|
Name : |
Mr. Sahil
Vazirally |
|
Designation : |
Director |
|
Address : |
381, Sarjapur Road,
Koramangala, III Block, Bangalore – 560034, Karnataka, India |
|
Date of Birth/Age : |
16.04.1978 |
|
Date of Appointment : |
09.04.2007 |
KEY EXECUTIVES
|
Name : |
Mr. Viswanathan |
|
Designation : |
Company Secretary |
MAJOR SHAREHOLDERS
As on 23.09.2005
|
Names of
Shareholders |
|
No. of Shares |
|
T. Rafeeq Ahmed |
|
4668 |
|
Masoom Master
& Suraiya Master |
|
33648 |
|
Suraiya Master
& Masoom Master |
|
19332 |
|
M. D. Narayan |
|
48000 |
|
Arif Vazirally |
|
110740 |
|
M. D. Balakrishna |
|
10000 |
|
Ashok Sinha |
|
2000 |
|
Nahid Vazirally |
|
12388 |
|
Anur Investments
Private Limited |
|
102176 |
|
Rishaad Vazirally |
|
7224 |
|
Sahil Vazirally |
|
7900 |
|
Beblec [India] Private
Limited |
|
36240 |
|
Nihal Alladin |
|
1492 |
|
Ahmed Mohammed
& Abdul Razak Osman |
|
1332 |
|
Mr. K. A. Wadood |
|
800 |
|
Mr. Shakir
Fazalbhoy |
|
4000 |
|
Mr. Ameer Aladdin |
|
168 |
|
Ms. Farah Aladdin |
|
164 |
|
Mr. Rajab
Vaziralli & Mrs. Noorjehan Vazirally |
|
4980 |
|
Mrs. Noorjehan
Vazirally & Rajab Vaziralli |
|
4668 |
|
Mr. T. Adnan
Ahmed |
|
2668 |
|
Mr. T. Faizan
Ahmed |
|
2664 |
|
TOTAL |
|
417252 |
Equity Share Breakup (Percentage of Total Equity)
As on 30.09.2007
|
Category |
|
Percentage |
|
Bodies corporate
(not mentioned above) |
|
40.00 |
|
Directors or
relatives of directors |
|
43.00 |
|
Others |
|
17.00 |
|
Total |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing and exporting of Calcium Sodium and its
compounds, and other chemicals. |
||||||
|
|
|
||||||
|
Products : |
GLOBOGLUCO® - Gluconates Calcium Gluconate Calcium Lactate
Gluconate Calcium
Boro-Gluconate Sodium Gluconate Magnesium
Gluconate Manganese
Gluconate Potassium
Gluconate Zinc Gluconate Ferrous Gluconate Magnesium Lactate
Gluconate Copper Gluconate GLOCITRO®-Citrates Calcium Citrate Potassium Citrate Magnesium Citrate GLOSCORBO® -
Ascorbates Calcium Ascorbate Sodium Ascorbate Magnesium Ascorbate GLOLACTOBIO® -
Lactobionates Lactobionic Acid Calcium Lactobionate Calcium Bromolactobionate GLOMALO® - Malates Calcium Malate Citrate GLORO® -
Orotates Calcium Orotate Potassium Orotate Magnesium Orotate Zinc Orotate GLOPYRO® - Pyruvates Calcium Pyruvate Magnesium Pyruvate Zinc Pyruvate GLOLACTO® -
Lactates Calcium Lactate Calcium Lactate Gluconate Magnesium Lactate Gluconate |
||||||
|
|
|
||||||
|
Exports to : |
Canada, Egypt, Iran, Pakistan, Poland, Spain, Switzerland
and USA |
||||||
|
|
|
||||||
|
Imports from : |
The Netherlands |
GENERAL
INFORMATION
|
No. of Employees : |
50 |
|
|
|
|
Bankers : |
|
|
|
|
|
Banking Relations : |
Satisfactory |
|
|
|
|
|
|
|
Auditors : |
|
|
Name : |
R. Subramanian
& Company Chartered Accountants, |
|
Address : |
S – 616, Manipal
Centre, No. 47, Dickenson Road, Bangalore – 560042, Karnataka, India |
|
|
|
|
Name : |
A S Ramanathan Chartered Accountant |
|
Address : |
No. 47, Dickenson Road, Bangalore-560042, Karnataka, India |
|
|
|
|
Memberships : |
Ř Confederation of Indian Industry Ř Indian Drug Manufacturers Association Ř CHEMEXIL |
|
|
|
|
Subsidiaries : |
Calcitech India
Private Limited CIN No. :
U32109TZ1989PTC008787 |
CAPITAL STRUCTURE
As on 29.09.2007
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
450000 |
Equity Shares |
Rs. 10/- each |
Rs. 4.500 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
417252 |
Equity Shares |
Rs. 10/- each |
Rs. 4.173 millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
4.173 |
4.172 |
4.172 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
136.031 |
116.490 |
104.395 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
140.204 |
120.662 |
108.567 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
105.316 |
82.536 |
64.401 |
|
|
2] Unsecured Loans |
0.250 |
0.250 |
0.250 |
|
|
TOTAL BORROWING |
105.566 |
82.786 |
64.651 |
|
|
DEFERRED TAX LIABILITIES |
29.971 |
31.471 |
21.173 |
|
|
|
|
|
|
|
|
TOTAL |
275.741 |
234.919 |
194.391 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
175.323 |
167.744 |
155.295 |
|
|
Capital work-in-progress |
0.000 |
5.812 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
15.893 |
18.383 |
19.256 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
33.357
|
24.042 |
15.856 |
|
|
Sundry Debtors |
50.302
|
30.522 |
22.400 |
|
|
Cash & Bank Balances |
13.551
|
2.262 |
1.540 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
59.614
|
34.929 |
40.440 |
|
Total Current Assets |
156.824
|
91.755 |
80.236 |
|
|
Less : CURRENT LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
48.595
|
27.133 |
40.274 |
|
|
Provisions |
23.904
|
21.642 |
20.122 |
|
Total Current Liabilities |
72.499
|
48.775 |
60.396 |
|
|
Net Current Assets |
84.325
|
42.980 |
19.840 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
275.741 |
234.919 |
194.391 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
|
|
|
|
|
|
Sales Turnover |
299.544 |
237.136 |
189.212 |
|
|
Other Income |
7.449 |
6.810 |
4.276 |
|
|
Total Income |
306.993 |
243.946 |
193.488 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
23.438 |
26.704 |
24.041 |
|
|
Provision for Taxation |
1.456 |
12.230 |
14.156 |
|
|
Profit/(Loss) After Tax |
21.982 |
14.474 |
9.885 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Financial Charges |
9.943 |
8.088 |
2.971 |
|
|
Increase/(Decrease) in Finished Goods |
0.000 |
[3.571] |
[1.708] |
|
|
Depreciation & Amortization |
14.569 |
13.022 |
5.459 |
|
|
Other Expenditure |
259.043 |
199.703 |
162.725 |
|
Total Expenditure |
283.555 |
217.242 |
169.447 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
PAT / Total Income |
(%) |
7.16
|
5.93 |
5.11 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
7.82
|
11.26 |
12.71 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
7.06
|
10.29 |
10.21 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.17
|
0.22 |
0.22 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
1.27
|
1.09 |
1.15 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.16
|
1.88 |
1.32 |
LOCAL AGENCY
FURTHER INFORMATION
Subject has been accredited with ISO 9002 Certification.
Form 8 Particular for creation or modification of charges
Bankers Charges
Report as per Registry
|
Name of the company |
GLOBAL CALCIUM PRIVATE LIMITED |
|
Presented By |
Mr.
Arif Vazirally, Managing Director |
|
1) Date and description of instrument creating the change |
Agreement for Demand Cash Credit on the hypothecation of movable property [Open Cash Credit] dated 28.11.84 Agreement for Bills purchased dated 28.11.84
All relate to the same charge |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Open Cash Credit [OCC] : Rs. 0.350 million Bills Purchased / Discounted : Rs. 0.250 million Total : Rs. 0.600 million |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
All the stock of raw materials, finished goods, goods-in-process, stores at Plot No. 126, SIPCOT Complex, Hosur and cheques, bills, hundis or other instruments with or without share certificates, government securities or other documents including railway receipts, bills of lading or other documents constituting title to goods attached. Covering book debts and receivables of the company |
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Terms and conditions are as per the attached leter & documents of Indian City Branch, Margin Money is 25% in respect of OCC and 10% in respect of Rate of Interest : 5.5% per annum over the |
|
5) Name and Address and description of the person entitled to the charge. |
Indian Bank Bangalore City Branch, Kempe Gowda Road, Bangalore – 560009, Karnataka, India |
|
6) Date and brief description of instrument modifying the charge |
Dated 25.07.2005 – 1. Hypothecation agreement creating second charge on plant / machinery, accessories, tools, movables 2. Letter ceding 2nd charge 3. Consent letter from Tamilnadu Industrial Investment Corporation Limited ceding second charge in favour of Indian Bank |
|
7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification. |
Creation of second charge in favour of the bank, on assets already created in favour of Tamilnadu Industrial Investment Corporation Limited, Hosur Branch, to the existing limits. |
|
This form is for |
Modification of
charge |
|
Charge
identification number of the modified
|
90006384 |
|
Corporate
identity number of the company |
U02429TZ1979PTC009946 |
|
Name of the
company |
GLOBAL CALCIUM
PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in India of the company |
No. 126, SIPCOT Industrial Complex, Hosur – 635126, Dharmapuri District, Tamilnadu, India |
|
Type of charge |
Book Debts Movable Property Immovable
Property |
|
Particular of
charge holder |
Indian Bank, Bangalore City Branch, 10, K. G. Road, Bangalore – 60001, Karnataka, India |
|
Nature of
description of the instrument creating or modifying the charge |
|
|
Date of
instrument Creating the charge |
15.03.2008 |
|
Amount secured by
the charge |
Rs. 93.500
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest
Existing- 1. OCC
– BPLR-presently 12.50%
Terms of
Repayment Three Months (for
ad hoc limit only) Existing: OCC,
PC/ FBP/ FBN.L/C, Perf. Guarantee – One year Term Loan- 6
equal monthly installments of rs. 0.300 Million each with a holiday period of
3 monthsl. Monthly interest to
be recovered then and there. Margin PC- 10%, OCC-
25%, FBP-5%, FBN-Nil, LC, Perf.Guarantee-10%, Money Guarantee-25% Extent and
Operation of the charge Pari passu first
charge on all the immovable assets (excluding two apartments owned by the Company
and windmill)p alongwith Tamilnadu Industrial Investment Corporation) |
|
Short particulars
of the property charged |
Land, Buildings,
Fixed Machinery and Plant situated at 125 and 126, Sipcot Industrial Complex,
Hosur-635126, Tamilnadu |
|
Date of latest
modification prior to the present modification |
02.11.2007 |
|
Particulars of
the present modification |
Adhoc Packing
Credit Limit of Rs. 5.000 Million availed. The total Packing Credit / FBP/
FBN now stands enhanced from 30.000 Millions to 35.000 Millions The present total
limits now stands: OCC- Rs. 20.000 Millions PC/FBP/ FBN-
35.000 Millions LC/ Pef.
Guarantee- 20.500 Millions Term Loan -18.000
Millions= 93.500 Millions |
WEBSITE DETAILS
Corporate
Global Calcium is the world's leading producer of high quality calcium
compounds and a full range of mineral gluconates, catering to the
pharmaceutical, nutraceutical, food and beverage sectors.
The Client includes all Major Specialty Pharmaceutical, Nutraceutical,
Consumer Health, Food & Beverages companies across the Globe.
Member of the Calcium Group of Companies, Global Calcium has
state-of-the-art 'ISO 9001:2000' and WHO-GMP certified production facilities in
Bangalore (India), that caters to the requirements of leading conglomerates
around the world meeting their need for active compounds that are used in human
and veterinary pharmaceuticals, nutraceuticals, food & beverages, health
care and cosmetics, besides a whole lot of other technical applications.
All the operations are driven towards business excellence within the
health care industry, offering clients a one-stop-shop for specialty bulk
ingredients that are used in various challenging applications, in a variety of
sterile and non-sterile pharmaceuticals, health products and mineral
supplements.
Founded in the early 1980's, Global Calcium has today emerged as a
strong and vibrant international company. Over the years, the close
relationship they have nurtured with market-leading pharmaceutical,
biotechnology, health care, food & beverage companies have provided great
value and forms the basis of the expertise and consultancy in the application
of calcium and mineral compounds.
The operations today comprise a suite of value added organic products
developed on leading business practices that ensure:
- Quality &
innovation across products and services
- Responsiveness
to customer needs
- Punctuality
in deliverables
- Continued
customer service and support
- Customer
delight
- Cost
effectiveness
- Flexibility
Location :
Global Calcium is located in the city of Bangalore. The city is globally
recognized as the Silicon Valley of Asia due to several Fortune 500 companies
having their research and development facilities present in and around the
city.
Global Calcium operates out of this professional environment in
Bangalore, with a wide spread of marketing and product support offices in India
and also through a network of business associates in other parts of the world.
India offers a very conducive business environment for manufacturing of
API, which has resulted in the business presence of pharmaceutical majors, who
have leveraged on the huge people talent, wide range of specialty products,
extensive markets network and low operational cost advantages which the country
offers.
Consequently, India has the second largest pharmaceutical industry in
the world by volume, with the majority of produce being consumed by the export
markets.
The Global Group was initially conceptualized with the single objective
of starting a small but highly quality conscious company, to produce Calcium
Gluconate for the famed Swiss pharmaceutical major SANDOZ in the late 1970's.
In the early 1980's, Calcium India was approached by the erstwhile Glaxo
to develop Calcium Lactobionate for a challenging application. Global Calcium
was born out of this need and the group today produces over 2000 MT of various
calcium salts and mineral gluconates each year.
Management Team
All their operations are driven towards business excellence within the
health care industry, offering clients a one-stop-shop for specialty bulk
ingredients that are used in various challenging applications, in a variety of
sterile and non-sterile pharmaceuticals, health products and mineral
supplements.
Founded in the early 1980's, Global Calcium has today emerged as a
strong and vibrant international company. Over the years, the close relationship
they have nurtured with market-leading pharmaceutical, biotechnology, health
care, food & beverage companies have provided great value and forms the
basis of their expertise and consultancy in the application of calcium and
mineral compounds.
Their management team consists of Technocrats and entrepreneurs from
backgrounds ranging from pure science to Investment Banking to Consulting and
highly skilled professionals in Pharmacology, Chemistry, Quality Assurance and
Engineering.
All their directors have strong domain expertise in the life sciences
segments and their stewardship in several leading trade bodies nationally and
internationally.
Products :
With 25 years experience Global Calcium has a comprehensive product
range that is applied across a range of industries.
Details of Global Calcium's products, including grades, concentrations,
shelf life, bacterial count, etc, can be accessed by clicking on the
corresponding product below.
They would be delighted to offer you a sample with COA of any of their
products to demonstrate the excellent quality of all their products.
Research and
Development
Research and Development at Global Calcium ensures a complete focus
program that covers chemical analysis, stability studies, physical analysis,
safety assurance, formulation and new product development and quality
assurance.
The multidisciplinary R&D approach followed at Global Calcium offers
greater efficacy and superior safety profiles for the products, tested through
state-of-the-art equipment such as HPLC, HPTLC, UV-Spectrophotometer, GC, BOD
incubators, etc.
The team of focused PhDs, MScs and focused specialists conduct extensive
testing and development pilot trials using optimized process upgrades towards
improved yields. The R&D team drives these initiatives towards offering
cost advantages to the customers.
The routine R&D activities cover chemical analysis and certification
according to USP, BP, EP and JP; Physical tests for assay, bulk density, pH,
etc.; Safety tests adhering to WHO-GMP standards and a quality assurance
program that commences from the stage of sourcing raw material till the final
dispatch of the products to their respective destination. Subsequently, they
are able to maintain an excellent quality track record.
The formulation and new product development team is constantly working
towards making effective combination salts and specialty calcium formulations
based on the application requirements. As a result, they have developed several
products with excellent properties for the calcium fortification of food and
beverage.
Global Calcium's research and development is based on working to improve
quality, create new products and increase applications with regards to the
market and customers.
Manufacturing
Global Calcium's manufacturing plants are fully cGMP compliant as per EU
Standards and have state-of-the-art manufacturing facilities.
They have multi-facilities with SS electro-chemical reactors, SS filters
& sparklers, chilling and evaporation crystallizes, centrifuging
facilities, crushing facilities, granulation & blending facilities, calcium
spray dryer technology – Large Scale, integrated water system, waste treatment
and auto packaging.
Hence they are positioned to offer clients end-to-end high quality
products, technology oriented, and optimized production practices.
The 5 independent manufacturing plants have a capacity to produce over
2000 MT of various Calcium and Mineral Gluconates salts the year around, making
them one of the world's largest producers in the world.
The facility has a dedicated Spray-Drying Unit that is designed to meet
the highest quality standards and optimize product-drying yields with improved
density control. The facility is entirely automated and has a capacity to
process 750 MT per annum. This is now being increased 1500 MT per annum.
Global Calcium has multi feeder and storage tanks, hot air generators,
alcohol storage tanks, cooling towers and complete generator power back up to
support power fluctuations and low voltage power conditions.
The waste treatment initiatives adhere to standards of the State
Pollution Control Board in handling gaseous and solid waste disposal and
recycling. They are one of the few companies of this scale to get an ISO 14001
accreditation. The entire manufacturing areas are supported by large gardens,
flowering trees and plants creating a picture perfect environment reiterating
the commitment to the enviroment with high safety standards.Global Calcium
understands that the right people make a difference to the pharmaceutical
business and employs only the best professional and highly qualified talent to
steer its operations
Clientele
Over the last 25 years, Global Calcium has forged strategic alliances
with several leading pharmaceutical, nutritional, food and beverage companies
around the world.
Current client list ranges across 45 countries across the globe.
Customer satisfaction is the biggest priority and all the 500+ employees
strive towards this parameter of success.
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.38 |
|
UK Pound |
1 |
Rs.81.34 |
|
Euro |
1 |
Rs.64.55 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
POINTS |
|
HISTORY |
1~10 |
7 |
|
|
PAID-UP CAPITAL |
1~10 |
7 |
|
|
OPERATING SCALE |
1~10 |
7 |
|
|
FINANCIAL CONDITION |
|
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
|
--PROFITABILIRY |
1~10 |
6 |
|
|
--LIQUIDITY |
1~10 |
7 |
|
|
--LEVERAGE |
1~10 |
7 |
|
|
--RESERVES |
1~10 |
7 |
|
|
--CREDIT LINES |
1~10 |
7 |
|
|
--MARGINS |
-5~5 |
- |
|
|
DEMERIT POINTS |
|
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
|
--LITIGATION |
YES/NO |
NO |
|
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
|
MERIT POINTS |
|
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
|
--AFFILIATION |
YES/NO |
YES |
|
|
--LISTED |
YES/NO |
NO |
|
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
|
TOTAL |
|
63 |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|